Company / Current Assets
Astria Therapeutics, Inc. Current Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$334.6M
FY2024
5-year range
$46.3M / $334.6M
FY2020-FY2024
Trend
+33.4%
vs FY2023
Sector context
#151 of 213
Health Care
What the data says
At $335M, Astria Therapeutics, Inc.'s current assets ranks #151 of 213 in the Health Care sector. Current Assets has increased for 7 consecutive years, from $17M in FY2017 to $335M in FY2024.
Based on SEC 10-K filings.
$335M in FY2024 with a 5-year CAGR of +53.7%.
Improved from $228M to $335M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +38.1%
- 5-Year CAGR
- +53.7%
- 10-Year CAGR
- -
Sector benchmark
#151 of 213 in Health CareTop 71% of 213This company $334.6M Sector average $2.5B
▼
-86.7% below sector average
Key checks
Key Insights
- Astria Therapeutics, Inc.'s current assets has grown for 7 consecutive years.
- 5-year CAGR of +53.7%, indicating consistent growth.
- In FY2024, current assets increased 33.4% year-over-year.
- Ranks #151 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $334.6M | +33.4% |
| FY2023 | $250.9M | +10.2% |
| FY2022 | $227.7M | +79.2% |
| FY2021 | $127.1M | +174.3% |
| FY2020 | $46.3M | +18.9% |
| FY2019 | $39.0M | +0.1% |
| FY2018 | $38.9M | +122.8% |
| FY2017 | $17.5M | -55.8% |
| FY2016 | $39.5M | -37.8% |
| FY2015 | $63.6M | +323.1% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026